Our results in vivo (Figure 7) showed that IL-6 significantly promote tumor growth in vivo compared with HCC with HCCLM3-IL6(-) cells (7659.0±215.4 mm3 versus 5567.4±254.4 mm3, P=.013). The gene discussed is IL6; the disease is hepatocellular carcinoma.